---
title: "NAVBQ.US (NAVBQ.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/NAVBQ.US/news.md"
symbol: "NAVBQ.US"
name: "NAVBQ.US"
parent: "https://longbridge.com/zh-HK/quote/NAVBQ.US.md"
datetime: "2026-03-17T22:49:35.162Z"
locales:
  - [en](https://longbridge.com/en/quote/NAVBQ.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NAVBQ.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NAVBQ.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/NAVBQ.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/NAVBQ.US/news.md)


# NAVBQ.US (NAVBQ.US) — 相關新聞

### [Provectus Biopharmaceuticals verlängert automatisches Umwandlungsdatum für Vorzugsaktien bis 2028](https://longbridge.com/zh-HK/news/274556313.md)
*2026-02-02T20:31:03.000Z*
### [Navidea Biopharmaceuticals, Inc. Files for Bankruptcy | NAVB Stock News](https://longbridge.com/zh-HK/news/260330509.md)
*2025-10-08T20:57:00.000Z*
> Navidea Biopharmaceuticals, Inc. has filed for Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the District of De

### [Navidea Biopharmaceuticals, Inc. Announces Extension of Authority to Implement a Reverse Stock Split | NAVB Stock News](https://longbridge.com/zh-HK/news/241292464.md)
*2025-05-21T18:52:00.000Z*
> Navidea Biopharmaceuticals, Inc. has extended its authority to implement a reverse stock split of up to 1-for-50,000 sha

### [Navidea Biopharmaceuticals Announces the Extension of Plan Designed to Protect NOLs and Other Tax Assets | NAVB Stock News](https://longbridge.com/zh-HK/news/233948001.md)
*2025-03-31T22:08:00.000Z*
> Navidea Biopharmaceuticals has extended its Section 382 Rights Agreement to April 7, 2027, originally set to expire in 2